Antiplatelet therapy for subarachnoid haemorrhage

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Dorhout Mees, S M ^b   Van Den Bergh, W M ^b   Algra, A ^b   Rinkel, Gabriel J E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 [4 (AMINOIMINOMETHYL)PHENYL] 1 PIPERAZINYL] 1 PIPERIDINEACETIC ACID; ABCIXIMAB; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID CALCIUM; ALBYLS; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; DEFIBROTIDE; DIPYRIDAMOLE; DISINTEGRIN; EPTIFIBATIDE; ILOPROST; KETANSERIN; KETOROLAC; LEVAMISOLE; MILRINONE; MOPIDAMOL; OZAGREL; PENTOXIFYLLINE; PICOTAMIDE; PROCAINAMIDE; PROSTACYCLIN; PROSTAGLANDIN E1; SULOCTIDIL; TETRAMETHYLPYRAZINE; THIOPHENE; TICLOPIDINE; TIROFIBAN; TRAPIDIL; TROMETAMOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CLINICAL TRIAL; CONFIDENCE INTERVAL; FOLLOW UP; HUMAN; OUTCOME ASSESSMENT; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 42749100763     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006184     Document Type: Review

References (19)

1. The ACROSS Group. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 2000;31(8):1843-50.
2. Brilstra EH, Rinkel GJE, Algra A, van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology 2000;55(11):1656-60.
3. de Rooij NK, linn FHH, van der Plas JAP, Algra A, Rinkel GJE. Incidence of subarachnoid hemorrhage: a ten year update of a systematic review with emphasis of role of region, gender, age and time trend. In preparation.
4. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. In: EggerM, Davey SmithG, AltmanDG editor(s). Systematic reviews in health care: meta-analysis in context. 2nd Edition. London: BMJ Publication Group, 2001.
5. Dorsch NW. Cerebral arterial spasm: a clinical review. British Journal of Neurosurgery 1995;9:403-12.
6. Hirashima Y, Hamada H, Kurimoto M, Origasa H, Endo S. Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2005;102:882-7.
7. Honma Y, Clower BR, Haining JL, Smith RR. Comparison of intimal platelet accumulation in cerebral arteries in two experimental models of subarachnoid hemorrhage. Neurosurgery 1989;24:487-90.
8. Hop JW, Rinkel GJE, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28(3):660-4.
9. Juvela S, Hillbom M, Kaste M. Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. Journal of Neurosurgery 1991;74:386-92.
10. Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 1995;82:945-52.
11. Okhuma H, Suzuki S, Kimura M, Sobata E. Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1991;22:854-9.
12. Okhuma H, Ogane K, Fujita S, Manabe H, Suzuki S. Impairment of anti-platelet-aggregating activity of endothelial cells after experimental subarachnoid hemorrhage. Stroke 1993;24:1541-6.
13. Patrono C. Aspirin as an antiplatelet drug. New England Journal of Medicine 1994;330:1287-94.
14. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004;35(8):1862-6.
15. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. In: Cochrane Database Systematic Reviews, 1, 2005.
16. Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. Journal of Neurology, Neurosurgery and Psychiatry 2000;68(3):337-41.
17. Toussaint LG, Friedman JA, Wijdicks EFM, Piepgras DG, Pichelmann MA, McIver JI, et al. Inuence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2004;101:921-5.
18. Vane JR, Botting RM. The mechanism of action of aspirin. Thrombosis Research 2003;110:255-8.
19. Vinge E, Brandt L, Ljunggren B, Andersson KE. Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage. Stroke 1988;19:644-7.